Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

New triple agonist drug produces substantial weight loss in diabetic patients

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and appearing in The Lancet shows that treatment with the new triple agonist therapy retatrutide results in substantial weight loss and improvements in blood sugar control in people living with obesity or overweight and type 2 diabetes—a population that…

New triple agonist drug produces substantial weight loss in diabetic patients

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

What A NEET PG Rank Leaves Undecided

For NEET PG candidates, a specialty decision is also a decision about supervision, clinical responsibility and future practice. During a ward round, a resident may recognise the likely diagnosis and still need help deciding what deserves attention first.

More from Thursday 1 October →